Surface Oncology ROE 2017-2019 | SURF

Current and historical return on equity (ROE) values for Surface Oncology (SURF) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Surface Oncology ROE for the three months ending September 30, 2019 was -48.88%.
Surface Oncology ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2019-09-30 $-0.02B $0.07B -19.10%
2019-06-30 $-0.02B $0.08B -17.30%
2019-03-31 $-0.02B $0.10B -13.92%
2018-12-31 $-0.01B $0.10B -9.03%
2018-09-30 $-0.05B $0.11B -128.57%
2018-06-30 $-0.04B $0.12B -494.12%
2018-03-31 $-0.03B $-0.02B 150.00%
2017-12-31 $-0.05B $-0.07B 274.63%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.086B $0.059B
Surface Oncology, Inc. is a clinical-stage immuno-oncology company. It develops therapies for the treatment of cancer. The company's product pipeline includes CD47, CD73, SRF231, SRF373, SRF617, SRF388 and SRF231 which are in clinical stage. Surface Oncology is based in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $159.868B 27.90
Medtronic (MDT) Ireland $159.853B 22.08
Stryker (SYK) United States $80.144B 26.95
Boston Scientific (BSX) United States $60.227B 28.43
Baxter (BAX) United States $46.348B 28.10
Essilor Luxottica (ESLOY) France $32.970B 0.00
Zimmer Biomet Holdings (ZBH) United States $30.400B 19.07
Lonza Group Ag (LZAGY) Switzerland $30.070B 0.00
Coloplast (CLPBY) Denmark $27.194B 41.97
Terumo (TRUMY) Japan $27.183B 0.00
ResMed (RMD) United States $23.349B 43.07
Smith & Nephew SNATS (SNN) United Kingdom $22.117B 0.00
Sunny Optical Technology (SNPTF) China $19.732B 0.00
Insulet (PODD) United States $11.904B 566.35
Bio-Rad Laboratories (BIO) United States $11.075B 53.16
Perrigo (PRGO) Ireland $7.998B 14.91
Canopy Growth (CGC) Canada $7.913B 0.00
William Demant Holdings (WILYY) Denmark $7.896B 0.00
DiaSorin S.p.A (DSRLF) Italy $7.357B 0.00
Hill-Rom Holdings (HRC) United States $7.341B 21.13
GN STORE NORD (GNNDY) Denmark $6.158B 0.00
Haemonetics (HAE) United States $5.446B 36.80
Shandong Weigao Medical Polymer (SHWGF) China $5.020B 0.00
NuVasive (NUVA) United States $4.013B 31.60
ICU Medical (ICUI) United States $3.880B 25.30
Neogen (NEOG) United States $3.553B 59.13
GW Pharmaceuticals (GWPH) United Kingdom $3.537B 0.00
Quidel (QDEL) United States $3.250B 30.84
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.132B 0.00
Agios Pharmaceuticals (AGIO) United States $3.123B 0.00
National Vision Holdings (EYE) United States $2.908B 65.64
Aurora Cannabis (ACB) Canada $2.168B 0.00
Cardiovascular Systems (CSII) United States $1.807B 0.00
InMode (INMD) Israel $1.563B 0.00
AtriCure (ATRC) United States $1.486B 0.00
TG Therapeutics (TGTX) United States $1.344B 0.00
Aphria (APHA) $1.331B 0.00
VAREX IMAGING (VREX) United States $1.175B 23.49
Phibro Animal Health (PAHC) United States $1.024B 19.17
NanoString Technologies (NSTG) United States $1.005B 0.00
PetIQ (PETQ) United States $0.873B 21.30
Eagle Pharmaceuticals (EGRX) United States $0.778B 29.81
Quanterix (QTRX) United States $0.752B 0.00
LeMaitre Vascular (LMAT) United States $0.729B 40.99
Lantheus Holdings (LNTH) United States $0.708B 17.68
Omeros (OMER) United States $0.674B 0.00
Cerus (CERS) United States $0.641B 0.00
Surmodics (SRDX) United States $0.548B 56.80
MacroGenics (MGNX) United States $0.529B 0.00
OraSure Technologies (OSUR) United States $0.490B 29.41
Organigram Holdings (OGI) Canada $0.451B 0.00
Meridian Bioscience (VIVO) United States $0.408B 14.02
HEXO (HEXO) $0.401B 0.00
Owens & Minor (OMI) United States $0.394B 14.58
Utah Medical Products (UTMD) United States $0.385B 27.90
Zynex (ZYXI) United States $0.331B 37.48
BioLife Solutions (BLFS) United States $0.310B 126.17
Bovie Medical (APYX) United States $0.274B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.256B 0.00
Female Health (VERU) United States $0.243B 0.00
Vapotherm (VAPO) United States $0.241B 0.00
Repro-Med Systems (KRMD) United States $0.233B 0.00
United Health Products (UEEC) United States $0.224B 0.00
Viemed Healthcare (VMD) United States $0.209B 22.00
Liberty Health Sciences (LHSIF) Canada $0.178B 0.00
Rockwell Medical (RMTI) United States $0.164B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.164B 0.00
Cytosorbents (CTSO) United States $0.149B 0.00
Fonar (FONR) United States $0.132B 9.32
Chimerix (CMRX) United States $0.117B 0.00
MTech Acquisition (KERN) United States $0.096B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.090B 0.00
United-Guardian (UG) United States $0.083B 20.95
MRI Interventions (MRIC) United States $0.078B 0.00
Nephros (NEPH) United States $0.077B 0.00
Chembio Diagnostics (CEMI) United States $0.074B 0.00
FSD PHARMA INC (HUGE) $0.049B 0.00
ImmuCell (ICCC) United States $0.039B 0.00
Trinity Biotech (TRIB) Ireland $0.030B 0.00
GUARDION HEALTH (GHSI) United States $0.024B 0.00
NF Energy Saving (BIMI) China $0.023B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.014B 0.00
Senestech (SNES) United States $0.010B 0.00
Capricor Therapeutics (CAPR) United States $0.008B 0.00
Valeritas Holdings (VLRX) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.005B 0.00
Akers Biosciences Inc (AKER) United States $0.002B 0.00